Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
New words:
AAA, Abbot, academic, accomplish, accomplished, accrual, adjuvant, affiliated, atherectomy, attainment, Avinger, AXGN, beneficiary, blended, Boehringer, breakthrough, bring, canagliflozin, catheter, certainty, chlorambucil, chronic, CLL, complicate, complying, confirmed, contesting, dalbavancin, delay, Depo, Depomed, device, difficulty, discretion, domestic, DR, drawn, Durata, eleventh, EMA, entry, EU, evenly, expert, facsimile, Fargo, finite, frequency, Gazyva, German, Glumetza, goal, HCL, headquartered, healthcare, illiquidity, indefinitely, Ingelheim, innovate, inoperable, inspection, insufficient, investigational, Invokana, Janssen, Janumet, Japan, joined, Kadcyla, Korea, large, Laser, LENSAR, leverage, LG, licensor, lien, linker, lumivascular, lymphocytic, metformin, overallotment, Paradigm, Pharmaceutica, power, prepayment, proposed, quickly, RBC, recoverable, representation, resale, reset, restated, Royal, short, sitagliptin, Spine, stable, statute, strategic, stream, successfully, suffer, surgery, taxane, thirteenth, tranche, trastuzumab, twelfth, uncooperative, undiscounted, untreated, Valeant, vi, vii, waived, warranty, XR
Removed:
agency, alleged, arisen, assert, basic, complaint, County, coupling, cytotoxic, declaring, discontinued, District, drop, efficiently, enforceable, exemption, experimental, fail, fighting, incur, internationally, Judicial, killing, launched, list, organized, paper, positive, potentially, prevail, receipt, redeemable, registration, reliance, reserve, response, seeking, shift, Singapore, sponsored, suggest, suit, thereunder, today, treasury, trial, tumor, unsecured, vigorously, Washoe
Filing tables
Filing exhibits
- 10-K Annual report
- 4.9 Second Supplemental Indenture
- 10.56 Form of Credit Agreement Between the Company and Certain Borrowers
- 10.58 Royalty Purchase and Sale Agreement Between the Company and Depomed
- 12.1 Ratio of Earnings to Fixed Costs
- 21.1 Subsidiaries of the Registrant
- 23.1 Concent of Independent Registered Public Accounting Firm
- 31.1 Certification of Principal Executive Officer
- 31.2 Certification of Principal Financial Officer
- 32.1 Certification by the Principal Executive Officer and Principal Financial Officer
- Download Excel data file
- View Excel data file
Related press release
PDLI similar filings
Filing view
External links
Exhibit 12.1
PDL BIOPHARMA, INC.
COMPUTATION OF RATIO OF EARNINGS TO FIXED CHARGES
(Unaudited)
(Amount in thousands, except for ratios)
For the Years Ended December 31, | ||||||||||||||||||||||||
2008 | 2009 | 2010 | 2011 | 2012 | 2013 | |||||||||||||||||||
Earnings: | ||||||||||||||||||||||||
Income before income taxes | $ | 243,334 | $ | 280,285 | $ | 150,370 | $ | 307,428 | $ | 327,133 | $ | 401,876 | ||||||||||||
Add: fixed charges | 14,285 | 19,430 | 43,578 | 36,153 | 29,097 | 24,931 | ||||||||||||||||||
Earnings | $ | 257,619 | $ | 299,715 | $ | 193,948 | $ | 343,581 | $ | 356,230 | $ | 426,807 | ||||||||||||
Fixed Charges: | ||||||||||||||||||||||||
Interest expense1 | $ | 14,219 | $ | 19,357 | $ | 43,529 | $ | 36,102 | $ | 29,036 | $ | 24,871 | ||||||||||||
Estimated interest portion of rent expense2 | 66 | 73 | 49 | 51 | 61 | 60 | ||||||||||||||||||
Fixed charges | $ | 14,285 | 19,430 | $ | 43,578 | $ | 36,153 | $ | 29,097 | $ | 24,931 | |||||||||||||
Ratio of earnings to fixed charges | 18.03 | 15.43 | 4.45 | 9.50 | 12.24 | 17.12 |
_____________________________________
1 Interest expense includes amortization of debt discount and expenses.
2 Represents the estimated portion of operating lease rental expense that is considered by us to be representative of interest and amortization of discount related to indebtedness.